Search results
PROMOTED
Stay up to date with the latest clinical evidence in transthyretin amyloid cardiomyopathy (ATTR-CM) with this video series spotlighting key cardiomyopathy updates presented at ESC Heart Failure Congress (HFA) 2026.In the first session, Dr Mathew Maurer (Columbia University, New York, US) takes a deep dive into the CARDIO-TTRansform data, exploring the current treatment landscape and ongoing unmet…
View more
Spotlight on HFA 2026: Updates on Cardiomyopathies
Added:
3 weeks ago
Video Series
Benefits of Spironolactone: Win Ratio Analysis of the TOPCAT Trial
Added:
7 months ago
Original Research
Added:
2 weeks ago
Heart Failure Association Congress 2026 — Dr Philippe Debonnaire (AZ Sint Jan, Brugge, BE) and Professor Victoria Delgado (University Hospital Germans Trias i Pujol, Badalona, SP) discuss the expanding role of advanced cardiac imaging in heart failure diagnosis and management, and what a more personalised, multimodality approach means for clinical practice.The conversation moves beyond…
View more
Added:
3 weeks ago
HFA Congress 2026 — Dr Ambarish Pandey (University of Texas Southwestern Medical Center, Texas, US) joins us to discuss findings on diuretic resistance drawn from TRANSFORM-HF, a large-scale, pragmatic, randomised clinical effectiveness trial comparing torsemide versus furosemide in patients hospitalised with heart failure.TRANSFORM-HF enrolled 2,973 patients across 60 US sites, randomising 1:1…
View more
Added:
1 week ago
Added:
2 years ago
HFA 24 - Prof Stefan Anker (Charité Campus Virchow-Klinikum, Berlin, DE) joins us in this succinct interview to outline the findings of the RELIEVE-HF trial (NCT03499236).RELIEVE-HF was designed to evaluate the safety and effectiveness of the V-Wave inter-atrial shunt system to reduce lung congestion in patients with advanced heart failure. 605 participants with New York Heart Association (NYHA)…
View more
Added:
18 hours ago
Prof Isabella Kardys (Erasmus MC University Medical Center, Rotterdam, NL) joins us to discuss how proteomic phenotyping, serial biomarkers and digital monitoring could enable more personalised, proactive heart failure care.Prof Kardys outlines work applying large-scale proteomics to HFpEF, where serial profiling of around 5,000 proteins in over 400 patients has revealed distinct subphenotypes…
View more
Added:
1 day ago
Dr Robert J Mentz (Duke University Medical Center, Durham, NC, US) joins us to discuss decision-making in cardio-kidney-metabolic (CKM) disease, focusing on how to sequence and individualise guideline-directed therapy when heart failure, renal dysfunction and metabolic disease coexist.Dr Mentz examines how competing priorities — decongestion, blood pressure and renal function — shape the order in…
View more
Added:
6 days ago
Prof Debasish Banerjee (St George's University Hospitals NHS Foundation Trust, London, UK) joins us to discuss the practical management of heart failure in patients with coexisting chronic kidney disease (CKD) and diabetes, and how to close the gap between guideline recommendations and everyday clinical practice.In this interview, Prof Banerjee addresses one of the central challenges in cardio…
View more
Added:
6 days ago
Dr Stephen J Greene (Duke University School of Medicine, Durham, NC, US) joins us to discuss the practical realities of delivering guideline-directed medical therapy (GDMT) in heart failure, and how clinicians and programmes can move more patients towards near-optimal treatment despite the constraints of everyday practice.In this interview, Dr Greene addresses the persistent gap between what…
View more